NF-?B p65 Antibody
Product name: | NF-?B p65 Antibody |
Source: | Mouse |
Purity: | >95% |
Buffer Formulation: | Purified recombinant fragment of human NF-?B p65 expressed in E. Coli. |
Applications: | WB |
Storage: | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
UOM: | 100ug |
NF-?B p65 Antibody
Catalog Number:IC215256
Product Profile
Product Name | NF-?B p65 Antibody |
---|---|
Antibody Type | Primary Antibodies |
Key Feature
Clonality | Monoclonal |
---|---|
Isotype | IgG1 |
Clone Number | 6H7 |
Host Species | Mouse |
Tested Applications | |
WB~~1:500 - 2000.:
|
|
Species Reactivity | |
Concentration | 1mg/ml |
Purification |
Target Information
Gene Synonyms |
NFKB3
|
---|---|
Alternative Names |
NFkappaB p65
More
p65 NFKB3 RELA |
MolecularWeight(MW) | 60219 Da |
Function |
NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1
More
|
Tissue Specificity | Purified recombinant fragment of human NF-?B p65 expressed in E. Coli. |
Cellular Localization | Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction (By similarity) Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS stimulation |
Database Links
Entrez Gene | 5970 |
---|---|
Nucleotide Accession | NP_068810.3 |
Application
-
Application
Figure 1: Western blot analysis using anti-NF-kB p65 mAb against Jurkat (1), K562 (2) and NIH/3T3 (3) cell lysate.
Application Notes |
WB~~1:500 - 2000.:
|
---|
Additional Information
Form | Liquid |
---|---|
StorageInstructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
Storage Buffer | Purified recombinant fragment of human NF-?B p65 expressed in E. Coli. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.